Ironwood Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $367K | Hold |
6,047
| – | – | 0.15% | 130 |
|
|
2025
Q4 | $326K | Hold |
6,047
| – | – | 0.14% | 134 |
|
|
2025
Q3 | $273K | Hold |
6,047
| – | – | 0.12% | 137 |
|
|
2025
Q2 | $280K | Sell |
6,047
-192
| -3% | -$9.43K | 0.14% | 130 |
|
|
2025
Q1 | $381K | Hold |
6,239
| – | – | 0.21% | 115 |
|
|
2024
Q4 | $353K | Hold |
6,239
| – | – | 0.18% | 125 |
|
|
2024
Q3 | $323K | Hold |
6,239
| – | – | 0.16% | 131 |
|
|
2024
Q2 | $259K | Hold |
6,239
| – | – | 0.14% | 134 |
|
|
2024
Q1 | $338K | Hold |
6,239
| – | – | 0.17% | 129 |
|
|
2023
Q4 | $320K | Hold |
6,239
| – | – | 0.17% | 127 |
|
|
2023
Q3 | $362K | Hold |
6,239
| – | – | 0.22% | 107 |
|
|
2023
Q2 | $399K | Hold |
6,239
| – | – | 0.23% | 110 |
|
|
2023
Q1 | $432K | Hold |
6,239
| – | – | 0.27% | 106 |
|
|
2022
Q4 | $449K | Hold |
6,239
| – | – | 0.3% | 103 |
|
|
2022
Q3 | $444K | Hold |
6,239
| – | – | 0.31% | 104 |
|
|
2022
Q2 | $480K | Sell |
6,239
-3,200
| -34% | -$244K | 0.32% | 101 |
|
|
2022
Q1 | $689K | Hold |
9,439
| – | – | 0.37% | 93 |
|
|
2021
Q4 | $589K | Hold |
9,439
| – | – | 0.29% | 109 |
|
|
2021
Q3 | $559K | Hold |
9,439
| – | – | 0.29% | 109 |
|
|
2021
Q2 | $631K | Hold |
9,439
| – | – | 0.32% | 105 |
|
|
2021
Q1 | $596K | Hold |
9,439
| – | – | 0.32% | 107 |
|
|
2020
Q4 | $586K | Hold |
9,439
| – | – | 0.34% | 98 |
|
|
2020
Q3 | $569K | Hold |
9,439
| – | – | 0.41% | 90 |
|
|
2020
Q2 | $555K | Sell |
9,439
-800
| -8% | -$47.9K | 0.43% | 91 |
|
|
2020
Q1 | $571K | Hold |
10,239
| – | – | 0.57% | 67 |
|
|
2019
Q4 | $657K | Sell |
10,239
-1,166
| -10% | -$66.8K | 0.45% | 80 |
|
|
2019
Q3 | $578K | Buy |
11,405
+4,300
| +61% | +$202K | 0.43% | 86 |
|
|
2019
Q2 | $322K | Hold |
7,105
| – | – | 0.25% | 120 |
|
|
2019
Q1 | $339K | Hold |
7,105
| – | – | 0.28% | 118 |
|
|
2018
Q4 | $369K | Hold |
7,105
| – | – | 0.34% | 111 |
|
|
2018
Q3 | $441K | Hold |
7,105
| – | – | 0.31% | 115 |
|
|
2018
Q2 | $393K | Hold |
7,105
| – | – | 0.28% | 125 |
|
|
2018
Q1 | $449K | Hold |
7,105
| – | – | 0.33% | 112 |
|
|
2017
Q4 | $435K | Hold |
7,105
| – | – | 0.31% | 118 |
|
|
2017
Q3 | $453K | Hold |
7,105
| – | – | 0.32% | 113 |
|
|
2017
Q2 | $396K | Hold |
7,105
| – | – | 0.29% | 119 |
|
|
2017
Q1 | $386K | Hold |
7,105
| – | – | 0.29% | 116 |
|
|
2016
Q4 | $415K | Hold |
7,105
| – | – | 0.3% | 116 |
|
|
2016
Q3 | $383K | Hold |
7,105
| – | – | 0.29% | 120 |
|
|
2016
Q2 | $523K | Sell |
7,105
-75
| -1% | -$5.3K | 0.39% | 104 |
|
|
2016
Q1 | $459K | Sell |
7,180
-1,500
| -17% | -$94.6K | 0.3% | 114 |
|
|
2015
Q4 | $597K | Hold |
8,680
| – | – | 0.25% | 105 |
|
|
2015
Q3 | $514K | Sell |
8,680
-750
| -8% | -$47.6K | 0.19% | 116 |
|
|
2015
Q2 | $627K | Hold |
9,430
| – | – | 0.14% | 114 |
|
|
2015
Q1 | $608K | Sell |
9,430
-2,170
| -19% | -$136K | 0.11% | 121 |
|
|
2014
Q4 | $685K | Hold |
11,600
| – | – | 0.12% | 118 |
|
|
2014
Q3 | $594K | Hold |
11,600
| – | – | 0.11% | 127 |
|
|
2014
Q2 | $563K | Hold |
11,600
| – | – | 0.09% | 131 |
|
|
2014
Q1 | $603K | Hold |
11,600
| – | – | 0.09% | 121 |
|
|
2013
Q4 | $617K | Sell |
11,600
-832
| -7% | -$42.4K | 0.09% | 122 |
|
|
2013
Q3 | $575K | Hold |
12,432
| – | – | 0.09% | 121 |
|
|
2013
Q2 | $556K | Buy |
+12,432
| New | +$540K | 0.1% | 120 |
|
Other funds holding BMY
VCM
VPM
Ironwood Investment Management's BMY Position: Q1 2026 in Review
Ironwood Investment Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 6,047 shares worth $367K. The position accounts for 0.15% of the portfolio, ranked #130.
Ironwood Investment Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $689K in Q1 2022. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Ironwood Investment Management held 6,047 shares of Bristol-Myers Squibb worth $367K as of Q1 2026.
- Ironwood Investment Management left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 0.15% of Ironwood Investment Management's portfolio in Q1 2026, its #130 holding.
- Ironwood Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Ironwood Investment Management's Bristol-Myers Squibb position peaked at $689K in Q1 2022.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Ironwood Investment Management's 13F filing for Q1 2026, filed 15 May 2026.